A phase II trial of sorafenib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC): A Southwest Oncology Group (SWOG) trial

被引：0
|
作者：
Williamson, S. K.
Moon, J.
Huang, C. H.
Guaglianone, P.
Wolf, G. T.
Urba, S. G.
机构：
[1] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
[2] Southwest Oncol Grp, Ctr Stat, Seattle, WA USA
[3] Canc Care Specialists Cent Illinois, Decatur, IL USA
[4] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6044
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase II evaluation of eribulin mesylate (E7389, NSC 707389) in patients with metastatic or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group trial S0618
    Susanne M. Arnold
    James Moon
    Stephen K. Williamson
    James N. Atkins
    Sai-Hong I. Ou
    Michael LeBlanc
    Susan G. Urba
    [J]. Investigational New Drugs, 2011, 29 : 352 - 359
  • [32] Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck
    Argiris, A.
    Kotsakis, A. P.
    Hoang, T.
    Worden, F. P.
    Savvides, P.
    Gibson, M. K.
    Gyanchandani, R.
    Blumenschein, G. R., Jr.
    Chen, H. X.
    Grandis, J. R.
    Harari, P. M.
    Kies, M. S.
    Kim, S.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 (01) : 220 - 225
  • [33] Phase II trial of irinotecan plus cisplatin in patients with recurrent or metastatic squamous carcinoma of the head and neck (RMHNC).
    Ikpeazu, CV
    Murphy, BA
    Kish, B
    Cmelak, A
    Shyr, Y
    Netterville, J
    Burkey, B
    Chung, C
    Yarbrough, W
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 508S - 508S
  • [34] Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinoma
    Massarelli, Erminia
    Ginsberg, Lawrence E.
    Lin, Heather
    Tran, Hai T.
    Lee, J. Jack
    Williams, Michelle D.
    Blumenschein, George R.
    Lu, Charles
    Kies, Merrill S.
    Papadimitrakopoulou, Vassiliki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [35] Phase 2 Trial of AT-101 in Combination With Docetaxel for Recurrent, Locally Advanced, or Metastatic Head-and-Neck Squamous Cell Carcinoma (HNSCC) Management of Recurrent Head-and-Neck Squamous Cell Carcinoma
    Sacco, A.
    Nor, J.
    Belile, E.
    Sukari, A.
    Chepeha, D.
    Bradford, C.
    Eisbruch, A.
    Wolf, G.
    Urba, S.
    Worden, F.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (02): : 507 - 507
  • [36] Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinoma
    Massarelli, E.
    Lin, H.
    Ginsberg, L. E.
    Tran, H. T.
    Lee, J. J.
    Canales, J. R.
    Williams, M. D.
    Blumenschein, G. R., Jr.
    Lu, C.
    Heymach, J. V.
    Kies, M. S.
    Papadimitrakopoulou, V.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 (07) : 1476 - 1480
  • [37] A Phase II study of Sorafenib (BAY 43-9006) in patients with recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC) and nasopharyngeal cancer (NPC)
    Chen, E.
    Winquist, E.
    Agulnik, M.
    Chin, S.
    Pond, G.
    Cheiken, R.
    Francis, P.
    Petrenciuc, O.
    Siu, L.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 297 - 297
  • [38] Interim analysis of the combination of durvalumab and cetuximab in a phase II trial of patients with recurrent and metastatic head and neck squamous cell carcinoma
    Gulati, Shuchi
    Palackdharry, Sarah
    Weatherford, Layne
    Wilson, Sarah
    Desai, Shireen
    Steele, Aubrey
    Riaz, Kashif
    Takiar, Vinita
    Draper, Trisha
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [39] Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma
    Shin, DM
    Glisson, BS
    Khuri, FR
    Ginsberg, L
    Papadimitrakopoulou, V
    Lee, JJ
    Lawhorn, K
    Gillenwater, AM
    Ang, KK
    Clayman, GL
    Callender, DL
    Hong, WK
    Lippman, SM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) : 1325 - 1330
  • [40] A Phase II Trial of Personalized Immunotherapy in Patients (pts) with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M HNSCC) That Have Progressed on Prior Immunotherapy
    Zandberg, D. P.
    Chen, J.
    Tatsuoka, C.
    Normolle, D. P.
    Ohr, J.
    Isett, B.
    Rahman, Z.
    Fenton, M.
    Gooding, W.
    Vujanovic, L.
    Bao, R.
    Marsh, C.
    Seastone, D.
    Gorantla, V.
    Pabla, S.
    Conroy, J.
    Ferris, R. L.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : E4 - E4
12345